|
Fusion gene ID: 8247 |
FusionGeneSummary for CPM_AVIL |
Fusion gene summary |
Fusion gene information | Fusion gene name: CPM_AVIL | Fusion gene ID: 8247 | Hgene | Tgene | Gene symbol | CPM | AVIL | Gene ID | 1368 | 10677 |
Gene name | carboxypeptidase M | advillin | |
Synonyms | - | ADVIL|DOC6|p92 | |
Cytomap | 12q15 | 12q14.1 | |
Type of gene | protein-coding | protein-coding | |
Description | carboxypeptidase Mrenal carboxypeptidaseurinary carboxypeptidase B | advillin | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | P14384 | O75366 | |
Ensembl transtripts involved in fusion gene | ENST00000546373, ENST00000551568, ENST00000338356, ENST00000549691, | ENST00000537081, ENST00000257861, ENST00000550083, | |
Fusion gene scores | * DoF score | 12 X 5 X 6=360 | 15 X 10 X 6=900 |
# samples | 12 | 16 | |
** MAII score | log2(12/360*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(16/900*10)=-2.49185309632967 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: CPM [Title/Abstract] AND AVIL [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | SARC | TCGA-DX-A1L0-01A | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000546373 | ENST00000537081 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
In-frame | ENST00000546373 | ENST00000257861 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
5CDS-intron | ENST00000546373 | ENST00000550083 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
In-frame | ENST00000551568 | ENST00000537081 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
In-frame | ENST00000551568 | ENST00000257861 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
5CDS-intron | ENST00000551568 | ENST00000550083 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
In-frame | ENST00000338356 | ENST00000537081 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
In-frame | ENST00000338356 | ENST00000257861 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
5CDS-intron | ENST00000338356 | ENST00000550083 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
intron-3CDS | ENST00000549691 | ENST00000537081 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
intron-3CDS | ENST00000549691 | ENST00000257861 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
intron-intron | ENST00000549691 | ENST00000550083 | CPM | chr12 | 69326458 | - | AVIL | chr12 | 58194995 | - |
Top |
FusionProtFeatures for CPM_AVIL |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CPM | AVIL |
Specifically removes C-terminal basic residues (Arg orLys) from peptides and proteins. It is believed to play importantroles in the control of peptide hormone and growth factor activityat the cell surface, and in the membrane-localized degradation ofextracellular proteins. {ECO:0000269|PubMed:12457462}. | Ca(2+)-regulated actin-binding protein. May have aunique function in the morphogenesis of neuronal cells which formganglia. Required for SREC1-mediated regulation of neurite-likeoutgrowth. Plays a role in regenerative sensory axon outgrowth andremodeling processes after peripheral injury in neonates. Involvedin the formation of long fine actin-containing filopodia-likestructures in fibroblast. Plays a role in ciliogenesis.{ECO:0000269|PubMed:20393563}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | >AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 753_819 | 717 | 820 | Domain | HP |
Tgene | >AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 753_819 | 710 | 813 | Domain | HP |
Tgene | >AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 731_819 | 717 | 820 | Region | Headpiece |
Tgene | >AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 731_819 | 710 | 813 | Region | Headpiece |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 109_116 | 717 | 820 | Region | Polyphosphoinositide binding |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 135_143 | 717 | 820 | Region | Polyphosphoinositide binding |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 1_731 | 717 | 820 | Region | Core |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 109_116 | 710 | 813 | Region | Polyphosphoinositide binding |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 135_143 | 710 | 813 | Region | Polyphosphoinositide binding |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 1_731 | 710 | 813 | Region | Core |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 145_185 | 717 | 820 | Repeat | Note=Gelsolin-like 2 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 24_73 | 717 | 820 | Repeat | Note=Gelsolin-like 1 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 262_306 | 717 | 820 | Repeat | Note=Gelsolin-like 3 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 403_454 | 717 | 820 | Repeat | Note=Gelsolin-like 4 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 525_565 | 717 | 820 | Repeat | Note=Gelsolin-like 5 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000257861 | - | 15 | 19 | 628_669 | 717 | 820 | Repeat | Note=Gelsolin-like 6 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 145_185 | 710 | 813 | Repeat | Note=Gelsolin-like 2 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 24_73 | 710 | 813 | Repeat | Note=Gelsolin-like 1 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 262_306 | 710 | 813 | Repeat | Note=Gelsolin-like 3 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 403_454 | 710 | 813 | Repeat | Note=Gelsolin-like 4 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 525_565 | 710 | 813 | Repeat | Note=Gelsolin-like 5 |
Tgene | AVIL | chr12:69326458 | chr12:58194995 | ENST00000537081 | - | 15 | 19 | 628_669 | 710 | 813 | Repeat | Note=Gelsolin-like 6 |
Top |
FusionGeneSequence for CPM_AVIL |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_CPM_ENST00000546373_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_156aa MDFPCLWLGLLLPLVAALDFNYHRQEGMEAFLKTVAQNYSSVTHLHSIGKSVKGRKNIXTIKRRAGRCCCYHANHCXHEECNPLPEFXXQ >In-frame_CPM_ENST00000546373_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_156aa MDFPCLWLGLLLPLVAALDFNYHRQEGMEAFLKTVAQNYSSVTHLHSIGKSVKGRKNIXTIKRRAGRCCCYHANHCXHEECNPLPEFXXQ >In-frame_CPM_ENST00000551568_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_156aa MDFPCLWLGLLLPLVAALDFNYHRQEGMEAFLKTVAQNYSSVTHLHSIGKSVKGRKNIXTIKRRAGRCCCYHANHCXHEECNPLPEFXXQ >In-frame_CPM_ENST00000551568_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_156aa MDFPCLWLGLLLPLVAALDFNYHRQEGMEAFLKTVAQNYSSVTHLHSIGKSVKGRKNIXTIKRRAGRCCCYHANHCXHEECNPLPEFXXQ >In-frame_CPM_ENST00000338356_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_156aa MDFPCLWLGLLLPLVAALDFNYHRQEGMEAFLKTVAQNYSSVTHLHSIGKSVKGRKNIXTIKRRAGRCCCYHANHCXHEECNPLPEFXXQ >In-frame_CPM_ENST00000338356_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_156aa MDFPCLWLGLLLPLVAALDFNYHRQEGMEAFLKTVAQNYSSVTHLHSIGKSVKGRKNIXTIKRRAGRCCCYHANHCXHEECNPLPEFXXQ |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_CPM_ENST00000546373_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_469nt ATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCG TTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACA ATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAG TGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTA CCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAGCTCCAAATGAAGAA >In-frame_CPM_ENST00000546373_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_469nt ATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCG TTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACA ATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAG TGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTA CCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAGCTCCAAATGAAGAA >In-frame_CPM_ENST00000551568_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_469nt ATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCG TTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACA ATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAG TGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTA CCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAGCTCCAAATGAAGAA >In-frame_CPM_ENST00000551568_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_469nt ATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCG TTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACA ATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAG TGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTA CCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAGCTCCAAATGAAGAA >In-frame_CPM_ENST00000338356_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_469nt ATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCG TTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACA ATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAG TGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTA CCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAGCTCCAAATGAAGAA >In-frame_CPM_ENST00000338356_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_469nt ATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCG TTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACA ATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAG TGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTA CCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAGCTCCAAATGAAGAA |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_CPM_ENST00000546373_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_1073nt GTCTAGATTCTTCTTGGCCTCTCTGAGCAGCATTTCTTCCTTCTGCGTATGGGACAGGACCCTTTCTGGAATGGGGGTCTTATGACCTAC AATCAAACAAGAACATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGG AAGGGATGGAAGCGTTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGA AAAACATATGAACAATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTG AATTCTAATGACAGTGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCC AAAAAGGAGAATTACCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAG CTCCAAATGAAGAAAGAAAAGGGGCTTTTCTAAAGCAAGAAGGCCTATACCTATTGCAAGGCCACAGAAAAGAGCAGATAGTGCCAATAT CAGGAAATAATTTATCCACCAATTTCTGCCTGACATTCAGCTACTTAATTTAGATATAATAGAGTCTGCAAATCACGGCATGTTCTCCAT TTTTTCTCATCCTTGCATTCCTTGCTTGTTATATACCTAAAATGTTAACCATATAGTTTTTGGGTTTTGTGGCCCTCTAGCTAAAGCCTC AGCAGAAAGCACTAAAACTGCATAAATCTGGAGAAATCAAAAGAAAGAGAACCAAAAAACAATGCTTAAAATGTTTAATAACTTTATGTT TAATATTATACCAGGACCTACCTTTGTTTTCAATTTTAAGATGATTATTTCTAAAATCTATTTAGCCTGTAAATCATTGAAATCATATAT >In-frame_CPM_ENST00000546373_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_573nt GTCTAGATTCTTCTTGGCCTCTCTGAGCAGCATTTCTTCCTTCTGCGTATGGGACAGGACCCTTTCTGGAATGGGGGTCTTATGACCTAC AATCAAACAAGAACATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGG AAGGGATGGAAGCGTTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGA AAAACATATGAACAATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTG AATTCTAATGACAGTGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCC AAAAAGGAGAATTACCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAG >In-frame_CPM_ENST00000551568_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_1030nt ATAACACCCGGCCCCGCCGGGCGGCCGCGGGTGGGTAGAGGTGCGCGCCTGGGACCTGAACATGGACTTCCCGTGCCTCTGGCTAGGGCT GTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCGTTTTTGAAGACTGTTGCCCAAAACTACAG TTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACAATTAAAAGAAGAGCTGGGAGATGCTGCTG CTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAGTGAGCCAAAATATTACCCTATAGCAGTTC TGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTACCTCTCTGAACAGGACTTTGTGTCTGTGT TTGGCATCACAAGAGGGCAATTTGCAGCTCTGCCTGGCTGGAAACAGCTCCAAATGAAGAAAGAAAAGGGGCTTTTCTAAAGCAAGAAGG CCTATACCTATTGCAAGGCCACAGAAAAGAGCAGATAGTGCCAATATCAGGAAATAATTTATCCACCAATTTCTGCCTGACATTCAGCTA CTTAATTTAGATATAATAGAGTCTGCAAATCACGGCATGTTCTCCATTTTTTCTCATCCTTGCATTCCTTGCTTGTTATATACCTAAAAT GTTAACCATATAGTTTTTGGGTTTTGTGGCCCTCTAGCTAAAGCCTCAGCAGAAAGCACTAAAACTGCATAAATCTGGAGAAATCAAAAG AAAGAGAACCAAAAAACAATGCTTAAAATGTTTAATAACTTTATGTTTAATATTATACCAGGACCTACCTTTGTTTTCAATTTTAAGATG ATTATTTCTAAAATCTATTTAGCCTGTAAATCATTGAAATCATATATGCACTCCATAGGCAAAATCCAAATACCCAGATCTGTAATGTGT >In-frame_CPM_ENST00000551568_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_530nt ATAACACCCGGCCCCGCCGGGCGGCCGCGGGTGGGTAGAGGTGCGCGCCTGGGACCTGAACATGGACTTCCCGTGCCTCTGGCTAGGGCT GTTGCTGCCTTTGGTAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCGTTTTTGAAGACTGTTGCCCAAAACTACAG TTCTGTCACTCACTTACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACAATTAAAAGAAGAGCTGGGAGATGCTGCTG CTATCATGCGAATCACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAGTGAGCCAAAATATTACCCTATAGCAGTTC TGTTGAAAAACCAGAATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTACCTCTCTGAACAGGACTTTGTGTCTGTGT >In-frame_CPM_ENST00000338356_chr12_69326458_-_AVIL_ENST00000537081_chr12_58194995_-_1016nt CCCTCATGTGTTCTCAGGTTCTTCTTATTTTTATTCATCTCTAGAACATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGG TAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCGTTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACT TACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACAATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATC ACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAGTGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAG AATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTACCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGA GGGCAATTTGCAGCTCTGCCTGGCTGGAAACAGCTCCAAATGAAGAAAGAAAAGGGGCTTTTCTAAAGCAAGAAGGCCTATACCTATTGC AAGGCCACAGAAAAGAGCAGATAGTGCCAATATCAGGAAATAATTTATCCACCAATTTCTGCCTGACATTCAGCTACTTAATTTAGATAT AATAGAGTCTGCAAATCACGGCATGTTCTCCATTTTTTCTCATCCTTGCATTCCTTGCTTGTTATATACCTAAAATGTTAACCATATAGT TTTTGGGTTTTGTGGCCCTCTAGCTAAAGCCTCAGCAGAAAGCACTAAAACTGCATAAATCTGGAGAAATCAAAAGAAAGAGAACCAAAA AACAATGCTTAAAATGTTTAATAACTTTATGTTTAATATTATACCAGGACCTACCTTTGTTTTCAATTTTAAGATGATTATTTCTAAAAT CTATTTAGCCTGTAAATCATTGAAATCATATATGCACTCCATAGGCAAAATCCAAATACCCAGATCTGTAATGTGTCAAAGCATTTTTCA >In-frame_CPM_ENST00000338356_chr12_69326458_-_AVIL_ENST00000257861_chr12_58194995_-_516nt CCCTCATGTGTTCTCAGGTTCTTCTTATTTTTATTCATCTCTAGAACATGGACTTCCCGTGCCTCTGGCTAGGGCTGTTGCTGCCTTTGG TAGCTGCGCTGGATTTCAACTACCACCGCCAGGAAGGGATGGAAGCGTTTTTGAAGACTGTTGCCCAAAACTACAGTTCTGTCACTCACT TACACAGTATTGGGAAATCTGTGAAAGGCAGGAAAAACATATGAACAATTAAAAGAAGAGCTGGGAGATGCTGCTGCTATCATGCGAATC ACTGCTGACATGAAGAATGCAACCCTCTCCCTGAATTCTAATGACAGTGAGCCAAAATATTACCCTATAGCAGTTCTGTTGAAAAACCAG AATCAGGAGCTGCCTGAGGATGTAAACCCTGCCAAAAAGGAGAATTACCTCTCTGAACAGGACTTTGTGTCTGTGTTTGGCATCACAAGA |
Top |
FusionGenePPI for CPM_AVIL |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CPM | ELAVL1, CAPZA2, DBN1, FLNA, GAK, MYH9, PPP1CC, RAB7A, PDLIM7, ATP6AP2, SYNPO, MAPRE1, GOLT1B, LIMA1, ANLN, MYO19, ZSCAN12, ULBP1, FTH1, TBC1D22B, GTPBP3 | AVIL | CRK, RBSN, DDX11, DUS3L, FIGNL1, SCYL1, DOCK7, VIL1, TMOD2, RICTOR, RIPK4, DCTN6, MCM8, THUMPD3, BRIP1, MYO5C, ALMS1, MYO1F, TUBA4A, TUBB8, MYO1B, MYO5A, USP47, C14orf80, TUBB3, DDX11L8, WDR59, BBS1 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CPM_AVIL |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CPM_AVIL |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CPM | C0014175 | Endometriosis | 1 | CTD_human |
Hgene | CPM | C0037116 | Silicosis | 1 | CTD_human |